Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Non-Small-Cell Lung × palbociclib × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 35 Ovarian Neoplasms 6 Neoplasm Metastasis 5 Pancreatic Neoplasms 4 Neoplasms 4 Lymphoma, Non-Hodgkin 4 Endometrial Neoplasms 4 Carcinoma, Renal Cell 4 Multiple Myeloma 3 Lymphoma 3 Glioma 3 Wilms Tumor 2 Uterine Cervical Neoplasms 2 Sarcoma, Ewing 2 Sarcoma 2 Rhabdomyosarcoma 2 Rhabdoid Tumor 2 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Osteosarcoma 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neuroblastoma 2 Medulloblastoma 2 Lymphoma, Mantle-Cell 2 Lung Neoplasms 2 Liposarcoma 2 Leukemia, Myeloid, Acute 2 Kidney Neoplasms 2 Histiocytosis, Langerhans-Cell 2 Hepatoblastoma 2

Interventions

pembrolizumab 134 Carboplatin 123 Pemetrexed 106 Cisplatin 79 Paclitaxel 62 Nivolumab 49 durvalumab 45 osimertinib 43 Specimen Handling 41 Docetaxel 41 atezolizumab 31 Magnetic Resonance Spectroscopy 31 Gemcitabine 28 cemiplimab 25 130-nm albumin-bound paclitaxel 22 Ipilimumab 21 Radiotherapy 20 Bevacizumab 20 Radiosurgery 19 amivantamab 18 Drug Therapy 18 Cetuximab 18 lazertinib 12 Immunoglobulin G 12 tislelizumab 11 Taxes 11 Disulfides 11 Biopsy 11 adagrasib 10 Standard of Care 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04606446 2026-04-16

KAT6

Pfizer

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡